Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Gynecol Oncol. 2016 Aug 17;143(2):326–333. doi: 10.1016/j.ygyno.2016.08.231

Figure 2. Resource trade-offs associated with candidate triage algorithms compared with current guidelines.

Figure 2

ASC-US = Atypical squamous cells of undetermined significance; HPV, human papillomavirus; LSIL = Low-grade intraepithelial lesion; ohrHPV, positive for non HPV-16/-18 high-risk genotypes.

Colored bars denote percentage change in total costs per woman, total number of cytologies, total number of HPV tests, total number of colposcopies, and total number of treatments, of each alternative strategy compared with current guidelines in Norway (i.e., co-testing at 12 months). The strategies are sorted by increasing change in costs.